M-HC AC 1%
Natural health product licensed in Canada
- Licence holder
- Mantra Pharma Inc.
- NPN or DIN-HM
- 80066165
- Status
- Active licence
- Licence date
- 31 December 2015
- Revision date
- 2 February 2016
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Acétate d'hydrocortisone | 1 Pour cent |
Non-medicinal ingredients
Paraffinum liquidum, Phénoxyéthanol, (p)-hydroxybenzoate de propyle, Cétéareth-20, Poly(sorbate) 85, Eau, (p)-hydroxybenzoate de méthyle, Alcool cétéarylique, Copolymère d'acrylates/acrylamide
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 12 years | Not specified | Not specified |
| Sub Pop to be created | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
For temporary relief of minor skin irritations associated with redness, itching, dryness and scaling. For temporary relief of minor skin irritations, rashes, itching and redness due to eczema, insect bites, poison ivy, poison oak, poison sumac, contact dermatitis (e.g. caused by soaps, detergents, cosmetics or jewellery), seborrheic dermatitis or psoriasis. Anti-pruritic. Anti-itch. For temporary relief of external genital, feminine itching. For temporary relief of external anal itching due to hemorrhoids.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use in or around the eyes. Do not apply to large areas. Do not use on children 2 years of age or younger, except on the advice of a health care practitioner. Do not use for the treatment of diaper rash, except on the advice of a health care practitioner. Do not use to treat vulvar itching associated with a vaginal discharge, except on the advice of a health care practitioner.
- Précautions et mises en garde
For external use only. If symptoms worsen or persist more than 7 days or clear up and occur again within a few days, stop use of this product and do not begin use of any other hydrocortisone product unless directed by a health care practitioner. In case of bleeding, consult a health care practitioner promptly.
Source
Official Health Canada record, licence 80066165
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging